Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.

CONCLUSION: In this retrospective series, metastatic CRPC patients who started first-line docetaxel with a low pretreatment NLR had a significantly better survival. In addition to known prognostic factors, NLR can be useful to improve prognostic evaluation of patients in this setting.
PMID: 28068151 [PubMed - as supplied by publisher]

Source: Acta Oncologica - January 8, 2017 Category: Cancer & Oncology Authors: Buttigliero C, Pisano C, Tucci M, Vignani F, Bertaglia V, Iaconis D, Guglielmini P, Numico G, Scagliotti GV, Di Maio M Tags: Acta Oncol Source Type: research